HSBC Holdings
CLYM

HSBC Holdings’s Climb Bio CLYM Stock Holding History

HSBC Holdings’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,744
Closed -$99.2K – 3294
2025
Q4 		$99.2K Buy
24,744
+12,800
+107% +$30.7K ﹤0.01% 2791
2025
Q3 		$23.9K Sell
11,944
-1,352
-10% -$2.51K ﹤0.01% 2671
2025
Q2 		$16.2K Sell
13,296
-3,430
-21% -$4.27K ﹤0.01% 2987
2025
Q1 		$21.4K Sell
16,726
-22
-0.1% -$36 ﹤0.01% 2966
2024
Q4 		$30K Buy
+16,748
New +$60.6K ﹤0.01% 3037

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return